Understanding how a specific gene affects seizures and migraines
Control of Seizure and Migraine Susceptibility by GPR37L1
This study is looking at how a specific gene might make some people more likely to have seizures and migraines, especially those who have both, by exploring how it affects certain brain cells; it's designed for anyone interested in understanding the genetic factors behind these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10886043 on NIH RePORTER |
What this research studies
This research investigates the role of the GPR37L1 gene in the susceptibility to seizures and migraines, particularly in individuals who experience both conditions. By studying how variations in this gene affect astrocytes, a type of brain cell, the research aims to uncover the cellular mechanisms that contribute to these neurological disorders. The project involves examining the behavior of genetically modified mice and human brain organoids to understand how these genetic variations influence brain function and disease susceptibility.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a family history of epilepsy and migraines or those who experience both conditions.
Not a fit: Patients with isolated epilepsy or migraines without a genetic link to GPR37L1 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments or preventive strategies for patients suffering from epilepsy and migraines.
How similar studies have performed: Previous studies have shown promising results in understanding the genetic basis of epilepsy and migraines, suggesting that this approach could yield valuable insights.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Hall, Randy a. — Emory University
- Study coordinator: Hall, Randy a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.